相关实验视频

Updated: Sep 9, 2025

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

通过β-catenin介导的心脏重编程,从外围血液中介干细胞衍生出来的外分细胞提高了交感性消神效果

Lan Zhao^1,2, Chen Li¹, Zhichuan Huang¹

¹Department of Cardiology, Guangzhou Red Cross Hospital of Ji-Nan University, Guangzhou, China.

Clinical and translational medicine

|September 5, 2025

概括

在心肌梗塞后,从外围血液中介质干细胞衍生的外体增强神经再生. 这种联合治疗激活了Wnt/β-catenin通路,改善了心脏功能和存活率.

科学领域:

心血管研究
复原医学
干细胞生物学

背景情况:

心肌梗塞 (MI) 导致心肌细胞损失和交感过度激活,导致心力衰竭.
神经损伤 (RD) 可以减弱交感信号和调节心脏功能.
由外周血液中酶干细胞 (PBMSC) 衍生出来的外体细胞 (Exos) 显示出组织修复的潜力.

研究的目的:

在猪模型中研究PBMSC-Exos是否可增强心脏中介性心脏再生.
阐明潜在的分子机制,包括特定的微RNA和信号通路的作用.

主要方法:

猪心肌梗塞模型与减少的喷射分数.
治疗组包括虚假的RD,RD和与PBMSC-Exos联合的RD.
评估心脏功能 (排泄分数),存活率,纤维化和分子标记 (miRNAs,Wnt/β-catenin通路).

主要成果:

与单一治疗相比,联合RD和Exos疗法显著改善了射出分数 (11% - 26%) 和存活率.
PBMSC-Exos将miR-141-200-429集群转移到心肌细胞中,促进重新编程和激活Wnt/β-catenin通路.
这种激活涉及Dkk1的抑制和GSK3β的酸化,导致心肌存活率提高和纤维化减少.

结论:

通过通过miR-141-200-429激活Wnt/β-catenin通路,PBMSC-Exos显著增强了心脏中介性心脏修复.
这种组合治疗是治疗心脏病发作心力衰竭的新有效策略.
当与外体治疗等补充干预措施相结合时, RD 保持有效性和安全性.

关键词:

急性心肌梗塞心脏重编程外体细胞微型RNA 乙-氨酸

更多相关视频

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

Modified Mouse Embryonic Stem Cell based Assay for Quantifying Cardiogenic Induction Efficiency

Modified Mouse Embryonic Stem Cell based Assay for Quantifying Cardiogenic Induction Efficiency

Published on: April 22, 2011

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...